Written by
Science and Humans
Written by
Science and Humans
Medically approved by
Maria Jacob
Last updated
8/10/2025 5:30:00 AM
Share
Rybelsus and Ozempic are both options commonly discussed in the treatment of type 2 diabetes and are also used in weight management programs. While they contain the same active ingredient, they differ in format, dosage frequency, and price—factors that may impact your personal preference and treatment plan.
Feature | Rybelsus | Ozempic |
---|---|---|
Form | Oral tablet | Prefilled pen |
Frequency | Once daily | Once weekly |
Available Doses | 3 mg, 7 mg, 14 mg | 0.25 mg, 0.5 mg, 1 mg, 2 mg |
Pen Sizes | Not applicable | Pen options vary by dose |
Retail Price Range (CAD) | $800–$900/month | $800–$1,000/month |
Program Access | Offered through Science & Humans' virtual care model, with eligibility screening required |
Both medications are available in Canada through programs like Science & Humans, which offer virtual assessments with licensed providers. The price for a 4-week supply typically ranges from $800 to $1,000, depending on the dose selected. Your final cost may be reduced if you have private insurance or access to a manufacturer savings program.
Choosing the right option depends on your health goals, lifestyle, and preferences. At Science & Humans, our clinical team will review your medical history, provide a requisition for blood work, and help determine the most appropriate plan for you.
Whether you're new to these options or considering a switch, our weight loss and hormone optimization programs offer:
DisclaimerThis content is intended for educational purposes only and should not be interpreted as medical advice. Always consult a licensed healthcare provider for personalized recommendations. |
While both Rybelsus and Ozempic contain the active ingredient semaglutide and belong to the same class of medications (GLP-1 receptor agonists), they differ in form and administration. Rybelsus is an oral tablet taken daily, whereas Ozempic is an injectable taken weekly .
The cost of Rybelsus and Ozempic can vary based on location, insurance coverage, and other factors. In general, Rybelsus tends to be slightly more affordable than Ozempic. However, it's essential to check with local pharmacies and insurance providers for specific pricing and coverage details in Canada .
Switching between Rybelsus and Ozempic should be done under the guidance of a healthcare provider. They can help you transition safely and monitor your response to the new medication. Factors such as dosage adjustments, potential side effects, and overall treatment goals should be considered during the switch.
Clinical studies have shown that Ozempic generally leads to more significant weight loss compared to Rybelsus. However, individual results can vary, and other factors such as personal preferences, lifestyle, and overall health should be considered when choosing a medication.
As of now, Rybelsus is primarily approved for the treatment of type 2 diabetes. It is not specifically approved for weight loss. However, weight loss can be a beneficial side effect for many patients. For updates on approvals, consult local health authorities or your healthcare provider.
References:
|